Company Profiles

driven by the PitchBook Platform

PanOptica

Description

Provider of therapies for sight-threatening diseases.The company caters to the healthcare industry and offers therapies for the treatment of age-related muscular degeneration and diabetic retinopathy.

2009

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$45M

Latest Deal Amount

$79M

Total Amount Raised

Description

Provider of therapies for sight-threatening diseases.The company caters to the healthcare industry and offers therapies for the treatment of age-related muscular degeneration and diabetic retinopathy.

Website:

www.panopticapharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Healthcare Services

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

150 Morristown Road Suite 205 Bernardsville, NJ 07924United States +1 (908) 766-2202
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore PanOptica's full profile, request a free trial.

    PanOptica Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    PanOptica Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    PanOptica Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    NovoCorporate Venture CapitalMinority000 0000000 0000
    SV Life Sciences AdvisersVenture CapitalMinority000 0000000 0000
    Third Rock VenturesVenture CapitalMinority000 0000000 0000
    Novo Corporate Venture Capital
    SV Life Sciences Advisers Venture Capital
    Third Rock Ventures Venture Capital

    PanOptica Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Paul ChaneyBoard Member, Co-Founder, President & Chief Executive Officer
    Lori ForrestExecutive Director, Finance & Controller
    Kristine CurtissExecutive Director, Clinical Operations
    Martin Wax MDCo-Founder, Chief Medical Officer & Executive Vice President, Research & Development
    David Bingaman Ph.DSenior Director, Clinical Development
    Paul Chaney Board Member, Co-Founder, President & Chief Executive Officer
    Lori Forrest Executive Director, Finance & Controller
    Kristine Curtiss Executive Director, Clinical Operations
    Martin Wax MD Co-Founder, Chief Medical Officer & Executive Vice President, Research & Development
    David Bingaman Ph.D Senior Director, Clinical Development

    PanOptica Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Bruce PeacockSV Life Sciences AdvisersVenture Partner000 0000
    Colin GoddardSelfBoard Member000 0000
    David Guyer MDSV Life Sciences AdvisersVenture Partner000 0000
    Kevin StarrThird Rock VenturesCo-Founder & Partner000 0000
    Thomas Dyrberg MDNovoManaging Partner, Ventures000 0000
    Bruce Peacock Venture Partner SV Life Sciences Advisers
    Colin Goddard Board Member Self
    David Guyer MD Venture Partner SV Life Sciences Advisers
    Kevin Starr Co-Founder & Partner Third Rock Ventures
    Thomas Dyrberg MD Managing Partner, Ventures Novo
    Request full access to PitchBook